
Sign up to save your podcasts
Or
This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421
4.3
3030 ratings
This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421
133 Listeners
315 Listeners
165 Listeners
861 Listeners
488 Listeners
19 Listeners
277 Listeners
91 Listeners
136 Listeners
58 Listeners
191 Listeners
349 Listeners
18 Listeners
250 Listeners
425 Listeners